B rugada syndrome (BrS) is an inherited disorder, affecting predominantly men in their forties 1 and associated with an increased incidence of sudden cardiac death. It presents with an ECG expression of atypical right bundle-branch block (RBBB) pattern and ST-segment elevation (STE) in leads V1 through V3.
B rugada syndrome (BrS) is an inherited disorder, affecting predominantly men in their forties 1 and associated with an increased incidence of sudden cardiac death. It presents with an ECG expression of atypical right bundle-branch block (RBBB) pattern and ST-segment elevation (STE) in leads V1 through V3. 1, 2 It is estimated that BrS causes ≈20% of sudden cardiac death in cardiac patients with structurally normal hearts. 1 Understanding its pathophysiological mechanisms is essential for improving risk stratification, diagnosis, and treatment to prevent sudden cardiac death.
Clinical Perspective on p 1959
BrS is considered a primary electric cardiac disease, because no structural anomalies are detected by conventional imaging. Up to 30% of patients test positive for mutations in the SCN5A gene, 1 which causes a loss-of-function of the cardiac sodium channel (I Na ). A Brugada ECG pattern can be provoked, in some affected patients with a normal baseline ECG pattern, by administration of I Na blockers.
There are 2 leading hypotheses for mechanisms underlying BrS phenotype and arrhythmias. (1) The abnormal repolarization hypothesis (based on the canine wedge preparation) [3] [4] [5] : Phase 1 notch is present in epicardial action potentials (APs) owing to a high density of transient outward current (I to ), but absent in endocardial APs (low I to density). A reduced I Na in BrS exaggerates the phase 1 notch preferentially in right ventricular outflow tract (RVOT) epicardium, where I to is expressed with maximal density. The resulting voltage gradients give rise to STE on the ECG. Further outward shift of the balance between I Na and I to can repolarize the membrane during phase 1 below the voltage range for L-type calcium channels (I Ca-L ) activation. When I Ca-L fails to activate, the AP loses its plateau (dome). Spatially heterogeneous loss of the AP plateau in the RVOT can lead to reentry (termed "phase-2 reentry" by Antzelevitch and colleagues). ( 2) The abnormal conduction hypothesis (based on whole-heart studies in BrS patients) [6] [7] [8] : Impaired I Na in structurally deranged tissue causes slow discontinuous AP propagation. Asynchronous activation can promote reentrant arrhythmias and create voltage gradients, causing STE and fractionation on the ECG. Data from catheter mapping 6 showed that delayed conduction and abnormal electrograms (EGMs) with low voltage and fractionated late potentials (reflecting slow discontinuous conduction) were exclusively localized in the anterior aspect of the RVOT epicardium. Catheter ablation in this area normalized the Brugada ECG and prevented ventricular tachycardia. The pathophysiological mechanisms of the abnormal ECG and arrhythmia in BrS are still a subject of debate.
Although much is known at the molecular and cellular scales, understanding the cause of the BrS ECG pattern and associated arrhythmias requires detailed characterization of the electrophysiological (EP) substrate in the intact hearts of BrS patients. This requires high-resolution, panoramic EP mapping of the ventricles and cannot be achieved with invasive catheter mapping. The recent development of noninvasive mapping with electrocardiographic imaging (ECGI) allowed us to obtain the first high-resolution panoramic EP data from BrS patients, including up to 1500 unipolar epicardial EGMs and epicardial maps of activation and repolarization. [9] [10] [11] [12] [13] [14] [15] Based on these data recorded during sinus rhythm (SR), we characterized the EP substrate in BrS patients in an effort to provide insight into the mechanistic origin of the BrS phenotype. The results show that both repolarization and structurally based conduction abnormalities coexist in the hearts of BrS patients. We also compared the BrS EP substrate with non-BrS RBBB (generally considered benign) to determine whether the substrate is specific to BrS, and whether ECGI can differentiate between these 2 pathologies with similar ECGs.
Methods

Patient Population
Twenty-five BrS patients from 2 centers in the United States and 1 center in France were enrolled. Details on patient recruitment are provided in online-only Data Supplement Methods. The BrS diagnosis was based on the consensus criteria 1 and was the basis for patient recruitment. Beyond the consensus criteria, pregnant women and children were excluded. Patient demographic data are provided in onlineonly Data Supplement Table I . Six RBBB patients with a prolonged QRS >120 ms were studied for comparison. All BrS and RBBB patients had no evidence of structural heart disease on echocardiography or MRI. Data from 7 healthy subjects 12 provided normal control. Subject characteristics are provided in online-only Data Supplement Table II . Protocols were approved by the institutional review boards at the 3 centers; written informed consent was obtained from all patients.
Noninvasive Mapping
ECGI methodology was described previously [9] [10] [11] [12] [13] [14] ( Figure IA in the online-only Data Supplement). In brief, torso surface ECG potentials, recorded simultaneously from 250 electrodes, were combined mathematically with patient-specific heart-torso geometry from ECG-gated computed tomography to construct epicardial potentials, unipolar EGMs, and maps of epicardial activation and repolarization. Bipolar EGMs were constructed for fractionation analysis. The method was validated extensively for reconstruction of EGMs, 9, 10 activation, 11, 12 and repolarization. 10, 12 Additional validation references are provided in online-only Data Supplement References.
Spatial properties of the EP substrate were determined by dividing the epicardium into 6 segments based on computed tomography images (online-only Data Supplement Table III ; the RVOT is depicted in Figure IB in the online-only Data Supplement). EGMs from valvular regions were excluded. On average, 1154 EGMs/patient were used for analysis.
EGMs were evaluated for morphology, magnitude, and fractionation. EGM Brugada morphology was defined as STE followed by T-wave inversion. EGM magnitude was measured peak-to-peak during the EGM QRS; for fractionated EGMs, the measurement was confined to the fractionated segment. Fractionation was expressed as number of low-amplitude deflections per EGM and displayed on epicardial EGM deflection maps. 13 For the fractionation analysis, bipolar EGMs were approximated by time derivatives of unipolar EGMs.
Local activation time (AT, referenced to beginning of QRS in ECG lead II) was determined by the maximal negative slope of the EGM during QRS inscription ( Figure IC in the online-only Data Supplement). From the ATs, epicardial activation isochrone maps were created. Slow conduction is represented by crowded isochrones. Regional activation duration (AD) was defined as the interval between the earliest and latest AT in a region, considering all EGMs in that region.
Local recovery time (RT) was determined from the maximal positive slope of the EGM T wave ( Figure IC in the online-only Data Supplement); it reflects the sum of local activation time and local action potential duration (APD). For a given activation sequence, RT determines spatial voltage gradients during repolarization, and underlies ST-T deflections. RT dispersion provides substrate for unidirectional block and reentry. Activation-recovery interval (ARI) was defined as the difference between RT and AT. ARI is independent of AT and a surrogate for local APD. 16 Epicardial RT and ARI gradients were computed as the difference between neighboring epicardial nodes, divided by the distance between them.
ECGI was conducted in 6 patients during increased heart rate (HR; 3 with exercise and 3 with isoprenaline). ECGI maps at baseline and during the faster HR were compared.
Simulation
The O'Hara-Rudy model of a human ventricular myocyte 17 was used in the simulations. Fast/late I Na and I to were replaced by formulations used previously to represent the prominent phase 1 repolarization notch characteristic of RVOT APs. 18 The model was paced to steady state at normal and slow rates (1000 beats at 1 and 0.5 Hz, respectively) with various combinations of reduced I Na and enhanced I to conductances (G Na and G to ). Combinations were selected to span a virtual Brugada severity space. APD was measured at 90% repolarization (APD90 in milliseconds).
Statistical Analysis
For every subject, the mean values for EGM variables within each epicardial segment were computed. All statistical tests were performed at the level of epicardial segments. Differences in variables among epicardial segments were compared by 1-way repeated-measures analysis of variance. When the assumption of sphericity was violated, Greenhouse-Geisser correction was performed. Using the Bonferroni method, pairwise comparisons between RVOT and other regions were conducted (5 tests in total). Continuous variables at baseline and increased HR were compared by paired t test. Continuous variables between BrS and control and between BrS and RBBB were compared by unpaired t test. The Satterthwaite modified t test was used for variables with unequal variances. All tests with P<0.05 were considered statistically significant. Statistical analysis was performed by using SPSS v19. Table 1 summarizes the values of EGM parameters in each epicardial segment for baseline HR. Pairwise multiple comparisons between the RVOT and other regions suggest that the abnormal substrate is localized in the RVOT. Figure 1 shows EGM characteristics and localization for representative examples in 3 BrS patients (normal maps are provided for reference). STE (examples in Figure 1A ) was observed in RVOT of all 25 patients (2.21±0.67 versus 0 mV in control, P<0.005), but rarely detected outside the RVOT. Three patients had lowmagnitude STE in the RV free wall and 2 had low-magnitude STE in the in the left ventricular (LV) free wall (range, 0.2-0.5 mV). ECG leads with STE for all patients are identified in Table  I Figure 1D shows EGMs from locations marked by white dots in Figure 1C , representative of abnormal morphology of RVOT EGMs. Red arrows indicate low voltage and fractionated EGMs.
BrS Activation
Normal human epicardial activation patterns during SR were reported previously. 12, 19 In general, earliest epicardial activation occurs in anterior RV (although there are many variants of location) 12, 19 and the lateral LV base is most commonly the latest region to activate. Activation isochrone maps in Figure 2A show examples of how SR epicardial activation patterns were altered by the presence of BrS EP substrate. Patient BrS#4 had the earliest epicardial breakthrough (asterisk) over the RV free wall, from which activation propagated slowly (crowded isochrones) across the RVOT-RV free wall border. RV free wall and LV activated first, leaving the anterior RVOT to activate last (light blue). Patient BrS#15 had a similar activation pattern, with a broader wavefront and faster activation of the RV free wall. Slow conduction occurred in the RVOT (crowded isochrones in the blue region). Patient BrS#20 had the earliest activation in the anterior RV. Latest activation (dark blue) occurred at the lateral RVOT, nearly 65 ms after the anterior RV breakthrough.
Of the 25 BrS patients imaged during SR, 20 demonstrated altered or delayed epicardial activation at the RVOT. Table 2 summarizes AT (mean±standard deviation) in each segment. AT in RVOT (82±18 versus 37±11 ms in control, P<0.005) was almost as late as that of LV base (80±16 ms), and was much delayed in comparison with the other 4 segments. In specific RVOT locations, AT was as late as 150 ms. AD (the time needed for activation of a defined region) was calculated for the RVOT (36±16 ms), the RV free wall (16±3 ms), the entire RV (40±14 ms), the entire LV (27±5 ms), and both ventricles (51±10 ms). RVOT activation took much longer than RV free wall or LV. AD of the RVOT accounted for ≈71% of total AD in both ventricles, highlighting the slow activation of the RVOT. Figure 2B and 2C shows representative ARI and RT maps from 3 BrS patients. Table 2 provides ARI and RT in each epicardial segment. ARI prolongation (318±32 versus 241±27 ms in control, P<0.005) and RT prolongation (381±30 versus 311±34 ms in control, P<0.005) were observed primarily in the RVOT, but also extended into adjacent neighboring regions of the RV free wall and the LV free wall. Steep epicardial ARI gradients and RT gradients (red arrows) occurred mostly at the RVOT-RV free wall or RVOT-LV free wall borders. These gradients also existed within the RVOT. Transitions of colors from blue to red across these regions reflect large differences in ARI and RT of 70 to 140 ms, leading to very steep localized ARI gradients (105±24 versus 7±5 ms/cm in control, 12 P<0.005) and RT gradients (96±28 versus 7±6 ms/cm in control, P<0.005). In patient BrS#15, the gradients between the anterior and lateral RVOT ARI map are not apparent in the RT map. This is because the anterior RVOT activated about 40 ms later than the lateral RVOT. This long delay masks the ARI differences between these 2 regions. However, in regions that activate without conduction delay (eg, RV free wall) RTs and their dispersion are primarily determined by ARI and ARI dispersion, independent of conduction. The patterns in RT maps closely follow the ARI patterns in such cases.
BrS Repolarization
Effects of Increased HR in BrS
ECGI was performed in 6 BrS patients during increased HR (mean increase from 71 to 133 bpm). Figure 3 shows the Figure 3A ), RVOT activation was further delayed with HR increase (AD, from 32±7 ms to 38±10 ms), and RVOT EGMs had more fractionation and lower voltage ( Figure 3D through 3F ). This change of RVOT EGMs was observed in 4 of 6 patients (no significant change in the other 2 patients). When HR increased, ARIs ( Figure 3B , corrected for HR) were shorter over the entire heart, but the RVOT ARIs decreased more than in other regions (by 50 ms in comparison with 25 ms in RV free wall). The regions with steep ARI gradients persisted, but the magnitude of the ARI gradient decreased (from 117 to 96 ms/cm). Reductions in RT and RT gradients were also observed during increased HR. STE ( Figure 3C ) in RVOT was significantly reduced (from 2.0 to 0.5 mV). Similar changes in ARI, RT, and STE were observed in all 6 patients (Table 3) .
Comparison Between BrS and Non-BrS RBBB
ECGI was conducted during sinus rhythm in 6 non-BrS patients with RBBB, without structural heart disease. Epicardial activation patterns, ARI maps, and EGM morphologies were analyzed and compared with those of the BrS patients. This comparison is of clinical importance, because the diagnosis of BrS in the presence of an RBBB ECG could be challenging. This is demonstrated in Figure 4A , where the Brugada ECG pattern for BrS#10 is masked by an RBBB pattern. Figure 4 shows representative data from 4 patients (2 BrS and 2 RBBB). BrS#4 had a spontaneous Brugada ECG pattern, whereas the ECG of BrS#10 showed an atypical RBBB pattern. 
Discussion
This is the first panoramic ventricular mapping study in BrS patients, made possible by ECGI. The panoramic mapping identified the RVOT as the region of abnormal EP substrate with the following properties: (1) abnormal EGMs characterized by STE and inverted T wave, reduced amplitude and fractionation; (2) conduction delays and regions of slow conduction; (3) prolonged repolarization and steep repolarization gradients; (4) reduced STE, increased fractionation, decreased RVOT ARI and RT, decreased ARI and RT gradients with increased HR. These properties are significantly different than in healthy controls (Table 4 ) and in patients with RBBB.
Abnormal EGM Characteristics and Localization
The RVOT has been suggested as the origin of arrhythmic activity in BrS patients. 1, 6, 8, 20, 21 Our observation of substrate localization exclusively to the RVOT in BrS patients provides crucial evidence for the RVOT dominant role in clinical BrS. This is in contrast to a recent ECGI study of the long QT syndrome, where abnormal repolarization substrate was spread over the entire epicardium. 15 ECGI revealed RVOT EGMs with coved morphology similar to the typical Brugada ECG morphology in the body surface right precordial leads (Figure 1) . Additionally, the EGMs were of low amplitude and fractionated. These EGM properties, reconstructed noninvasively by ECGI, were consistent with those obtained from invasive electroanatomical mapping. 6, 20 The ECGI panoramic mapping determined that the majority of these Brugada EGMs were confined to the RVOT; only rarely were they detected close to the RVOT, in adjacent neighboring regions of the RV or LV free wall. Therefore, our study adds insight to the observation from invasive epicardial mapping and ablation, that the Brugada morphology normalized following ablation in the anterior RVOT. 6 This EGMs localization confirms that the RVOT is the origin of the Brugada-type ECG morphology in the body surface right precordial leads.
Substrate for Abnormal Conduction
BrS has been considered a primary electric disease, because structural abnormalities have not been detectable by noninvasive clinical imaging (eg, echocardiography or MRI). Recently, RV interstitial derangements (fibrosis, fatty infiltration) have been found in endomyocardial biopsies of BrS patients, 7 and in the explanted heart of a BrS patient carrying an SCN5A mutation, as well. 22 Fibrosis and fatty infiltration have been associated with decreased electric coupling, discontinuous propagation, and reduced conduction velocity. 23 In the normal heart, excitability and conduction are dominated by I Na . In BrS, where I Na is impaired, I to becomes a significant determinant of excitability, opposing the depolarizing effect of I Na . This is especially true in the RVOT, where I to is expressed with very high density. In this region, the balance between reduced depolarizing I Na and large repolarizing I to results in a reduced excitatory current, which, on the background of a structurally abnormal substrate, can support long localized conduction delays and discontinuous slow conduction, conditions that facilitate sustained reentrant arrhythmias. 23 Experimental, theoretical, and clinical studies have shown that low-magnitude, fractionated, and wide EGMs reflect slow, nonuniform, and discontinuous conduction through a structurally heterogeneous substrate associated with separation and reduced coupling of myocardial fibers. 24 Previous studies demonstrated of ability ECGI to reconstruct EGMs with these properties. 9, 13, 14 In this study, ECGI reconstructed Figure 1D , red). The reconstructed unipolar EGMs and the approximated bipolar EGMs are consistent with those measured directly by catheters in BrS patients, 6, 20 providing evidence for slow discontinuous conduction in the RVOT. The ECGI mapping of late RVOT activation, prolonged AD, the presence of regions of slow conduction, and altered wavefront propagation in comparison with normal ( Figure 2A ) provides additional evidence supporting the conduction hypothesis. Similar observations were made with invasive mapping. 6, 20 Computer modeling of AP conduction in the presence of BrS mutant I Na also produced slow discontinuous conduction, causing spatial gradients of membrane potential during the AP plateau, and early repolarization phase and STE in the computed pseudo-ECG waveform. 25 Taken together, these data provide evidence for the presence of abnormal conduction in the RVOT of BrS patients.
Antzelevitch and colleagues used a canine RV wedge preparation, where I to activator and sodium and calcium channel blockers were applied to pharmacologically simulate effects of BrS, and to explain EGM fractionation and late potentials.
3,4
This preparation did not include structural abnormalities and conduction disturbances; it investigated the mechanism of EGM fractionation in the setting of abnormal repolarization alone. It demonstrated the ability to generate secondary deflections on the epicardial EGMs based on differences in the AP morphology at different epicardial locations during the AP repolarization phase. Following the phase 1 notch (which underlies the STE), APs can differ by the presence/amplitude of a dome and by the time of complete repolarization. The associated gradients can result in 2 late deflections on the EGM. 4 Because the deflections occur during late repolarization, the shortest coupling interval to the main EGM deflection (generated by the AP upstroke) was 200 ms. 4 In the patients studied here, and in patients studied by using catheters, 6 EGM fractionation shows different properties; it includes >2 deflections (many show 4 deflections) that are tightly coupled to the main deflection (<50 ms) and even occur before the main deflection. Moreover, the fractionation is amplified with increased heart rate. All of these properties point to fragmented slow conduction as a major contributor to EGM fractionation. Of course, abnormal repolarization can also contribute to fractionation of the EGM, 4 but the augmentation with increased heart rate identifies conduction as the major mechanism.
Substrate for Abnormal Repolarization
I to expression is nonuniform in the ventricular myocardium. Expression is highest in the epicardium and diminishes transmurally toward the endocardium, creating a phase 1 notch in epicardial, but not endocardial AP. A particularly large I to density is found in the epicardial RVOT. Reduced I Na in BrS on the background of the large I to exaggerates the phase 1 notch, and the resulting spatial gradients of membrane voltage can give rise to STE in ECG waveforms. The deep and wide notch delays the AP plateau and prolongs APD, potentially causing reversal of membrane voltage gradients and T-wave inversion. 3, 5 In extreme cases (not recorded in this study), the membrane is repolarized to voltages that are too low for sufficient I Ca-L activation during phase 1 of the AP and cells repolarize prematurely, losing the AP plateau. 3 This biphasic behavior (APD prolongation followed by APD shortening in conditions of extreme severity) is supported by the computer simulations of Figure 5 . ECGI was validated to accurately map regions of altered repolarization and steep repolarization gradients. 10 The ECGI mapping in this study (Figure 2 ) demonstrated delayed repolarization and prolonged epicardial APDs (based on reconstructed ARIs) in the RVOT of BrS patients. Short ARIs, closely coupled extrasystoles, or ventricular tachycardia were not recorded in any patient. Interestingly, direct recordings from endocardium and epicardium revealed longer ARIs in the epicardium than in the endocardium of BrS patients, suggesting prolongation of epicardial APD; ARI shortening was not reported. 26 A steep repolarization gradient existed at the RVOT borders, which could be attributable to nonuniform spatial expression of the mutation. However, even uniform spatial distribution of mutant-channel current can cause spatial ARI dispersion. APD is determined by a delicate balance of transmembrane currents and this dependence is nonlinear. Therefore, spatially uniform mutant I Na expression on the background of nonuniform electrophysiological profile (heterogeneous I to ) can cause large spatial variation of the APD. It is also possible that reduced coupling and fiber separation in the BrS substrate limit electric loading and help maintain the steep spatial repolarization gradients.
Examining the Coexistence of Conduction and Repolarization Substrates Using Increased HR
The rate dependence of STE and EGM fractionation in BrS may be helpful in unmasking the existence of abnormal repolarization and abnormal conduction, respectively, in the EP substrate. Decreased STE at increased HR supports the repolarization hypothesis, because it suppresses the AP phase 1 notch and associated voltage gradients. In this study, STE in the RVOT decreased in all 6 patients with increased HR. In contrast, increased EGM fractionation with increased HR reflects the presence of slow discontinuous conduction, consistent with the conduction hypothesis. Increased RVOT EGM fractionation was observed in 4 patients at faster HR. Taken together, the effects of increased HR on STE and EGM fractionation support coexistence of these 2 mechanisms in the BrS substrate. Repolarization abnormality is the major contributor to STE, whereas conduction abnormality is the major contributor to EGM fractionation.
From the arrhythmogenic perspective, the presence of steep repolarization gradients (dispersion) introduces asymmetry of excitability and thus conditions for unidirectional block. 23 Slow conduction shortens the wavelength of the reentrant AP, thus allowing for shorter reentry pathways and stabilizing reentry. Together, these 2 properties provide conditions for sustained reentrant excitation. Their coexistence in the substrate of BrS patients has been suggested by other recent studies 27, 28 ; it is consistent with the high incidence of arrhythmic sudden cardiac death. Interestingly, most arrhythmic events occur during bradycardia. Reduced STE at increased HR reflects less steep repolarization gradients; it reduces arrhythmogenicity because the probability for unidirectional block is reduced.
Comparison With Non-BrS RBBB
BrS and RBBB differ greatly in their arrhythmogenicity, with BrS being highly arrhythmogenic. Therefore, a noninvasive method for distinguishing between these abnormalities is highly desirable. Despite the similarities in the 12-lead ECG, ECGI differentiated BrS from non-BrS RBBB in several aspects: (1) BrS EGMs with STE, low voltage, and fractionation were not found in RBBB. (2) Nondelayed RV epicardial breakthrough was observed in all BrS patients, indicating involvement of a functioning RBB. RV breakthrough was absent in all RBBB patients, reflecting the defective conduction system. (3) In BrS, slow discontinuous conduction and delayed activation were confined to the RVOT and RVOT-RV border. In contrast, RBBB caused late activation of the entire RV because of a long conduction delay across the septum; there were no regional conduction delays within the RVOT/RV. (4) ARI prolongation and steep ARI gradients were observed in RVOT of BrS patients but not in RBBB patients. These differences could provide the basis for an ECGI-based differential diagnosis in the clinical setting. In addition, the BrS ECG pattern may be masked by an RBBB ECG pattern in some patients, causing difficulties in distinguishing between BrS and RBBB. This has led to invasive procedures (eg, RV pacing in Chiale intervention 29 ) that help unmask the Brugada phenotype in patients with RBBB. In this study, we demonstrated that ECGI can image the BrS substrate in such patients, providing a noninvasive method for the clinical diagnosis of BrS even when it is masked by an RBBB pattern on the body surface ECG.
Conclusions
Noninvasive ECGI reveals that the abnormal EP substrate in BrS patients is localized in the RVOT. Both abnormal repolarization and abnormal conduction are present in the substrate, leading to steep repolarization gradients and delayed activation. In addition, ECGI could differentiate BrS from RBBB based on differences in the patterns of activation and repolarization, and electrogram morphology. 
Limitations
Because this is the first ECGI study of BrS patients, it does not differentiate between subgroups (genotype, symptoms, family history, etc) within the BrS population.
ECGI data for the healthy controls were previously obtained with the same ECGI methodology; the data were not obtained at the time of this study.
This study is limited to characterizing the BrS substrate from data obtained during SR and relating its properties to the BrS ECG and EGM phenotype. Results demonstrate the existence of substrate with steep dispersion of repolarization and slow conduction, conditions that facilitate reentrant arrhythmias. However, arrhythmias were not recorded in any of the patients and the study does not provide direct information about the mechanism of ventricular tachycardia in BrS patients.
Typically, BrS I Na is reduced to ≈50% relative to control. Figure 5 shows simulated behavior for a large range of I Na reduction, paired with a range of I to to account for its high density in the RVOT. Deepening and broadening of the phase 1 notch, resulting in APD prolongation, is obtained for the entire range of I Na with G to ≥1.5 times control. The accentuated notch and resulting transmembrane voltage gradients contribute to STE in BrS EGMs. However, loss of the dome and APD shortening at 50% I Na required G to ≥3.3 times control (at 1-Hz pacing). A previously characterized BrS gain-of-function mutation in I to , L450F, was associated with a similarly large degree (≈3-fold) of current increase. 30 It should be mentioned that the simulations were conducted in an isolated cell. In the multicellular substrate of BrS hearts, electric loading on the AP dome during localized conduction delays (attributable to structural derangement) can contribute to premature repolarization, loss of the dome, and short APD. In the 25 patients studied here, short ARIs were never observed. Twenty-one BrS patients were offered the ECGI without heart rate acceleration. Nineteen patients participated, and two declined. The second period of recruitment ran from June 2013 to December 2013 to obtain ECG imaging (ECGI) recordings during sinus rhythm and heart rate acceleration. The heart rate acceleration protocol was added to the study after we completed analysis of the data from nineteen patients. The analysis suggested the usefulness of examining rate dependence to obtain insights into mechanisms. From eight patients that were offered the ECGI study, six participated and two declined.
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SUPPLEMENTAL MATERIAL
Right bundle branch block (RBBB) patients were recruited between January 2014 and April 2014 at Washington University. Patients who had RBBB ECG pattern with a prolonged QRS>120ms, no structural heart disease and no history of cardiac arrhythmia were included. Among fourteen patients that were offered the ECGI study, six participated, eight declined.
Historical data from 7 normal subjects (Main text, reference12) provided normal control. These data were previously obtained with the same ECGI methodology; they were not obtained at the time of this study. 
